Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency

with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases

Research output: Contribution to journalArticle

Abstract

Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.

Original languageEnglish
Pages (from-to)149-161
JournalAmerican Journal of Hematology
Volume94
Issue number1
DOIs
Publication statusPublished - 2019

Fingerprint

Congenital Hemolytic Anemia
Workflow
Enzyme Assays
Glycolysis
Pyruvate Kinase Deficiency of Red Cells
Guidelines
Enzymes
Surveys and Questionnaires

ASJC Scopus subject areas

  • Hematology

Cite this

Addressing the diagnostic gaps in pyruvate kinase deficiency : Consensus recommendations on the diagnosis of pyruvate kinase deficiency. / with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases.

In: American Journal of Hematology, Vol. 94, No. 1, 2019, p. 149-161.

Research output: Contribution to journalArticle

with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases 2019, 'Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency' American Journal of Hematology, vol. 94, no. 1, pp. 149-161. https://doi.org/10.1002/ajh.25325
with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases. / Addressing the diagnostic gaps in pyruvate kinase deficiency : Consensus recommendations on the diagnosis of pyruvate kinase deficiency. In: American Journal of Hematology. 2019 ; Vol. 94, No. 1. pp. 149-161.
@article{bd2b3d22a5fe42be8b459788be64f313,
title = "Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency",
abstract = "Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.",
author = "{with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases} and Paola Bianchi and Elisa Fermo and Bertil Glader and Hitoshi Kanno and Archana Agarwal and Wilma Barcellini and Stefan Eber and Hoyer, {James D.} and Kuter, {David J.} and Maia, {Tabita Magalh{\~a}es} and Ma{\~n}u-Pereira, {Maria del Mar} and Kalfa, {Theodosia A.} and Serge Pissard and Segovia, {Jos{\'e} Carlos} and {van Beers}, Eduard and Gallagher, {Patrick G.} and Rees, {David C.} and {van Wijk}, Richard",
year = "2019",
doi = "10.1002/ajh.25325",
language = "English",
volume = "94",
pages = "149--161",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Addressing the diagnostic gaps in pyruvate kinase deficiency

T2 - Consensus recommendations on the diagnosis of pyruvate kinase deficiency

AU - with the endorsement of EuroBloodNet, the European Reference Network in Rare Hematological Diseases

AU - Bianchi, Paola

AU - Fermo, Elisa

AU - Glader, Bertil

AU - Kanno, Hitoshi

AU - Agarwal, Archana

AU - Barcellini, Wilma

AU - Eber, Stefan

AU - Hoyer, James D.

AU - Kuter, David J.

AU - Maia, Tabita Magalhães

AU - Mañu-Pereira, Maria del Mar

AU - Kalfa, Theodosia A.

AU - Pissard, Serge

AU - Segovia, José Carlos

AU - van Beers, Eduard

AU - Gallagher, Patrick G.

AU - Rees, David C.

AU - van Wijk, Richard

PY - 2019

Y1 - 2019

N2 - Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.

AB - Pyruvate kinase deficiency (PKD) is the most common enzyme defect of glycolysis and an important cause of hereditary, nonspherocytic hemolytic anemia. The disease has a worldwide geographical distribution but there are no verified data regarding its frequency. Difficulties in the diagnostic workflow and interpretation of PK enzyme assay likely play a role. By the creation of a global PKD International Working Group in 2016, involving 24 experts from 20 Centers of Expertise we studied the current gaps in the diagnosis of PKD in order to establish diagnostic guidelines. By means of a detailed survey and subsequent discussions, multiple aspects of the diagnosis of PKD were evaluated and discussed by members of Expert Centers from Europe, USA, and Asia directly involved in diagnosis. Broad consensus was reached among the Centers on many clinical and technical aspects of the diagnosis of PKD. The results of this study are here presented as recommendations for the diagnosis of PKD and used to prepare a diagnostic algorithm. This information might be helpful for other Centers to deliver timely and appropriate diagnosis and to increase awareness in PKD.

UR - http://www.scopus.com/inward/record.url?scp=85057816461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057816461&partnerID=8YFLogxK

U2 - 10.1002/ajh.25325

DO - 10.1002/ajh.25325

M3 - Article

VL - 94

SP - 149

EP - 161

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -